About
Contact & Profiles
Research Areas
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Hemodynamic Monitoring and Therapy
- Sepsis Diagnosis and Treatment
Hospital do Coração
2025
ANDROMEDA-SHOCK 2 is an international, multicenter, randomized controlled trial comparing hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock to standard care test the hypothesis that former associated with lower morbidity and mortality terms of hierarchal analysis outcomes. To report statistical plan for ANDROMEDA--SHOCK clinical trial. We briefly describe design, patients, methods randomization, interventions, outcomes, sample size. portray our...
10.62675/2965-2774.20250140
article
EN
Critical Care Science
2025-01-01
Coming Soon ...